These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11746503)

  • 1. Differences in the uptake and nuclear localization of anti-proliferative heparan sulfate between human lung fibroblasts and human lung carcinoma cells.
    Cheng F; Petersson P; Arroyo-Yanguas Y; Westergren-Thorsson G
    J Cell Biochem; 2001; 83(4):597-606. PubMed ID: 11746503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding, internalization, and degradation of antiproliferative heparan sulfate by human embryonic lung fibroblasts.
    Arroyo-Yanguas Y; Cheng F; Isaksson A; Fransson LA; Malmström A; Westergren-Thorsson G
    J Cell Biochem; 1997 Mar; 64(4):595-604. PubMed ID: 9093909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate upregulates platelet-derived growth factor receptors on human lung fibroblasts.
    Malmström J; Westergren-Thorsson G
    Glycobiology; 1998 Dec; 8(12):1149-55. PubMed ID: 9858636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans.
    Westergren-Thorsson G; Onnervik PO; Fransson LA; Malmström A
    J Cell Physiol; 1991 Jun; 147(3):523-30. PubMed ID: 2066370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulphate/heparin glycosaminoglycans with strong affinity for the growth-promoter spermine have high antiproliferative activity.
    Belting M; Havsmark B; Jönsson M; Persson S; Fransson LA
    Glycobiology; 1996 Mar; 6(2):121-9. PubMed ID: 8727784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors.
    Westergren-Thorsson G; Persson S; Isaksson A; Onnervik PO; Malmström A; Fransson LA
    Exp Cell Res; 1993 May; 206(1):93-9. PubMed ID: 7683278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic analysis of fibroblast nuclear proteins after stimulation with mitogen activated protein kinase inhibiting heparan sulfate.
    Malmström J; Marchese J; Juhasz P; Pukac L; Karnovsky M; Marko-Varga G; Westergren-Thorsson G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):333-42. PubMed ID: 15652821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans.
    Yang YW; Yanagishita M; Rechler MM
    Endocrinology; 1996 Oct; 137(10):4363-71. PubMed ID: 8828497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican (heparan sulfate proteoglycan) is palmitoylated, deglycanated and reglycanated during recycling in skin fibroblasts.
    Edgren G; Havsmark B; Jönsson M; Fransson LA
    Glycobiology; 1997 Feb; 7(1):103-12. PubMed ID: 9061369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cell-surface glycosaminoglycans in human diploid fibroblasts during in vitro aging.
    Matuoka K; Mitsui Y
    Mech Ageing Dev; 1981 Feb; 15(2):153-63. PubMed ID: 6453260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role for Ext1-dependent heparan sulfate in regulating P311 gene expression in A549 carcinoma cells.
    Katta K; Sembajwe LF; Kusche-Gullberg M
    Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1472-1481. PubMed ID: 29580921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblasts weaken the anti-tumor effect of gefitinib on co-cultured non-small cell lung cancer cells.
    Yong X; Wang P; Jiang T; Yu W; Shang Y; Han Y; Zhang P; Li Q
    Chin Med J (Engl); 2014; 127(11):2091-6. PubMed ID: 24890158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of exogenous heparan sulfate with tumor cells of different metastatic phenotype.
    Timar J; Moczar M; Lapis K; Moczar E
    Invasion Metastasis; 1990; 10(5):301-15. PubMed ID: 2228518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of heparan sulfate into the nuclei of hepatocytes.
    Ishihara M; Fedarko NS; Conrad HE
    J Biol Chem; 1986 Oct; 261(29):13575-80. PubMed ID: 2944884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate proteoglycan expression in human lung-cancer cells.
    Nackaerts K; Verbeken E; Deneffe G; Vanderschueren B; Demedts M; David G
    Int J Cancer; 1997 Jun; 74(3):335-45. PubMed ID: 9221815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanism for lead inhibition of vascular endothelial cell proliferation: a lower response to basic fibroblast growth factor through inhibition of heparan sulfate synthesis.
    Fujiwara Y; Kaji T
    Toxicology; 1999 Apr; 133(2-3):147-57. PubMed ID: 10378481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular organization and antiproliferative domains of arterial tissue heparan sulfate.
    Schmidt A; Lemming G; Yoshida K; Buddecke E
    Eur J Cell Biol; 1992 Dec; 59(2):322-8. PubMed ID: 1493797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of cell surface heparan sulfates decreases the high affinity binding of basic FGF to endothelial cells, but not to FRTL-5 rat thyroid cells.
    Emoto N; Isozaki O; Ohmura E; Shizume K; Tsushima T; Demura H
    Thyroid; 1995 Dec; 5(6):455-60. PubMed ID: 8808095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the self-affinity of heparan sulfates from quiescent or proliferating normal 3T3 cells and from SV40-transformed cells.
    Fransson LA; Del Rosso M
    Acta Chem Scand B; 1985; 39(3):163-70. PubMed ID: 2986398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate degradation products can associate with oxidized proteins and proteasomes.
    Mani K; Cheng F; Fransson LA
    J Biol Chem; 2007 Jul; 282(30):21934-44. PubMed ID: 17540770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.